Drug Trial Radar · NCT03398148
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Jan 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,558
Actual
Start
Mar 7, 2018
Primary completion
Nov 9, 2022
Study completion May 11, 2023
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Jan 12, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to evaluate the efficacy and safety of risankizumab compared to placebo in inducing clinical remission in subjects with moderately to severely active UC.
Conditions
- Ulcerative Colitis (UC)
Interventions
risankizumab IVDrug
risankizumab intravenous (IV) infusion
placebo for risankizumabDrug
placebo for risankizumab
risankizumab SCDrug
risankizumab subcutaneous (SC) injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sub-Study 1: Percentage of Participants Achieving Clinical Remission Per Adapted Mayo ScoreTime frame: Week 12
- Sub-Study 2: Percentage of Participants Achieving Clinical Remission Per Adapted Mayo ScoreTime frame: Week 12
Locations
430 sites in 44 countries. Site status is shown where the registry gives one.
Southern California Res. Ctr. /ID# 169660
Coronado, California
Hoag Memorial Hosp Presbyterian /ID# 218348
Irvine, California
UC San Diego Health System /ID# 160452
La Jolla, California
United Medical Doctors /ID# 158528
Los Alamitos, California
Gastrointestinal Biosciences Clinical Trials, LLC /ID# 200931
Los Angeles, California
UCSF Center for Colitis and Crohn's Disease /ID# 201210
San Francisco, California
Cedars-Sinai Medical Center-West Hollywood /ID# 163851
West Hollywood, California
Peak Gastroenterology Associates, PC /ID# 165841
Colorado Springs, Colorado
Rocky Mountain Pediatric Gastroenterology /ID# 207174
Lone Tree, Colorado
Medical Research Center of CT /ID# 160311
Hamden, Connecticut
Yale Univ Digestive Diseases /ID# 213179
New Haven, Connecticut
South Lake Pain Institute, Inc /ID# 162878
Clermont, Florida
Ctr for Advanced Gastroenterol /ID# 202811
Maitland, Florida
University of Miami /ID# 160471
Miami, Florida
Coral Research Clinic /ID# 158584
Miami, Florida
South Florida Research Ph I-IV, Inc. /ID# 161848
Miami, Florida
Gastroenterology Group Naples /ID# 165212
Naples, Florida
Advanced Research Institute, Inc /ID# 161938
New Port Richey, Florida
Advent Health /ID# 160433
Orlando, Florida
Endoscopic Research, Inc. /ID# 206711
Orlando, Florida
Omega Research Group /ID# 203059
Orlando, Florida
Lenus Research & Medical Group /ID# 169730
Sweetwater, Florida
Clinical Research Trials of Florida, Inc. /ID# 201783
Tampa, Florida
AdventHealth Tampa /ID# 170503
Tampa, Florida
Gastroenterology Associates of Central Georgia, LLC /ID# 160523
Macon, Georgia
Atlanta Gastroenterology Spec /ID# 161372
Suwanee, Georgia
The University of Chicago Medical Center /ID# 160521
Chicago, Illinois
DM Clinical Research/Southwest /ID# 165012
Oak Lawn, Illinois
Indiana University /ID# 167252
Indianapolis, Indiana
Univ Kansas Med Ctr /ID# 226602
Kansas City, Kansas
Cotton-O'Neil Clinical Res Ctr /ID# 160412
Topeka, Kansas
Robley Rex VA Medical Center /ID# 218648
Louisville, Kentucky
Houma Digestive Health Special /ID# 158317
Houma, Louisiana
Delricht Research /ID# 206815
New Orleans, Louisiana
Nola Research Works, LLC /ID# 161368
New Orleans, Louisiana
Louisana Research Center, LLC /ID# 201204
Shreveport, Louisiana
Massachusetts General Hospital - Crohn's and Colitis Center /ID# 164255
Boston, Massachusetts
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 158524
Ann Arbor, Michigan
Clin Res Inst of Michigan, LLC /ID# 160327
Chesterfield, Michigan
Mayo Clinic - Rochester /ID# 200458
Rochester, Minnesota
Showing 40 of 430 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.